BCL2 and cancer: For instance, cancer prefers to express a high level of Bcl-2 [31,32], a pro-survival molecule, as one mechanism to overcome mitochondria-mediated apoptotic death, which leads to the development of Bcl-2 inhibitors as one potential management strategy to treat cancers [33,34].